Profile
Axel Nielsen has been Chief Operating Officer of deCODE genetics, Inc. since June 2007.
Previously, he was Chief Operating Officer of deCODE's US operations from June 1998 to 2002.
Mr. Nielsen was Vice President-Investor Relations, Vice President-Finance, Treasurer and Chief Financial Officer of deCODE genetics.
Before joining deCODE, he was with Icelandair, Inc. and McKinsey & Co. Mr. Nielsen received a BS degree in Computer Science and Finance from the University of Iceland and an MBA degree from MIT Sloan School of Management.
Former positions of Axel Nielsen
Companies | Position | End |
---|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Chief Operating Officer | 2009-12-31 |
Training of Axel Nielsen
University of Iceland | Undergraduate Degree |
Massachusetts Institute of Technology | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
- Stock Market
- Insiders
- Axel Nielsen